article thumbnail

Leveraging innate cell engagers for lymphoma treatment

European Pharmaceutical Review

Finally, Andreas looks at the prospects for antibodies that target the innate immune system in treating both haematological malignancies and solid tumours. As a result, when the patient’s lymphoma relapses after treatment with chemotherapy, BV and CPIs, there are no effective treatment alternatives for these patients.

article thumbnail

STAT+: Foundation charges cancer patients $83,000 for unproven but promising experimental drug

STAT

Still, when doctors told her last year that the cancer was growing despite two operations, radiation therapy, and a fifth regimen of chemotherapy, the retired business-meeting facilitator decided to do something unorthodox: spend $83,000 out of pocket on an unproven experimental cancer vaccine. Her husband said he had no regrets.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Rise in cancer among younger people worries and puzzles doctors

STAT

But other cancers have also increased in many countries, said Dr. Tomotaka Ugai, an instructor at Harvard Medical School who led the research. Gosline started a chemotherapy regimen that involves eight weeks of infusions followed by a four-week break. The role of obesity gets complicated when it comes to breast cancer.

article thumbnail

Developing point-of-care CAR T manufacturing

European Pharmaceutical Review

Bridging therapy has been shown to correlate with an inferior response to CAR T-cell therapy due to both progression of the chemotherapy-refractory malignant disease during the manufacturing period and increased toxicity. Car-t “The living drugs”, immune checkpoint inhibitors, and precision medicine: A new era of cancer therapy.